Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.

Alison G. Johnson is a corporate partner at Wilson Sonsini Goodrich & Rosati, where she focuses on the representation of emerging companies at all stages of growth, advising them on venture capital and other financings, mergers and acquisitions, private equity, and corporate governance matters. She also represents venture capital firms and angel investors.

Matthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.

Sara L. Patak is a partner in the Boulder office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on patent prosecution and intellectual property counseling, serving clients in a wide range of technology fields, including the pharmaceutical and biotechnology industries.

Meredith L. Krannich is an advisor in the Executive Advisory Program of Wilson Sonsini Goodrich & Rosati. Resident in the firm’s Salt Lake City office, she focuses on leveraging her nearly 20 years of experience in the life sciences sector as a lawyer and business executive to advise clients on a variety of legal operational and business matters.

Matthew G. Brown is Senior Director for Life Sciences Business Advisory at Wilson Sonsini Goodrich & Rosati. Based in San Diego, his practice focuses on advising early-stage life sciences companies with capital raises and strategic business development initiatives.